Open AccessImpact of low molecular weight heparin administration on the clinical course of the COVID-19 disease
Author(s) -
Burcu Yormaz,
Dilek Ergün,
Baykal Tülek,
Recai Ergün,
Uğur Arslan,
Fikret Kanat
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2006-184
Subject(s) - medicine , low molecular weight heparin , d dimer , gastroenterology , receiver operating characteristic , covid-19 , heparin , lymphocyte , c reactive protein , area under the curve , disease , inflammation , infectious disease (medical specialty)
Lymphopenia is the most important criterion of mortality and discharging feature for patients infected with coronavirus disease 2019 (COVID-19). This study aimed to investigate the clinical impact of a low molecular weight heparin (LMWH) treatment on the clinical course of COVID-19.